Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Target Cell Response to Hormones

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

What is Cell Signaling?

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.

What are Cells?

What are Cells?

Cells are the smallest and basic units of life, whether it is a single cell that forms the entire organism, e.g., in a bacterium or trillions of them, e.g., in humans. No matter what organism a cell is a part of, they share specific characteristics.
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...

Concentration Cells

Concentration Cells

A concentration cell is a type of a voltaic cell constructed by connecting two almost identical half-cells, both based on the same half-reaction and using the same electrode, differing only in the concentration of one redox species. A concentration cell's potential, therefore, is determined only by the concentration difference of the particular redox species.
Consider the following voltaic cell:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Single cell-resolved cellular, transcriptional, and epigenetic changes in mouse T cell populations linked to age-associated immune decline.

Proceedings of the National Academy of Sciences of the United States of America·2025

Same author

An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia.

bioRxiv : the preprint server for biology·2024

Same author

An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia.

Cancer research·2024

Same author

Combination of menin and kinase inhibitors as an effective treatment for leukemia with NUP98 translocations.

Leukemia·2024

Same author

Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.

Nature communications·2022

Same author

Current perspectives in T-ALL.

HemaSphere·2022

Search research articles

Related Experiment Video

Updated: Feb 2, 2026

Author Spotlight: Advancing Metabolomics Analysis of Rare Hematopoietic Stem Cells

Author Spotlight: Advancing Metabolomics Analysis of Rare Hematopoietic Stem Cells

Published on: February 23, 2024

Can one target T-cell ALL?

Adolfo Ferrando¹

¹Institute for Cancer Genetics, Columbia University, 1130 St Nicholas Ave., ICRC 401B, New York, NY, 10032, USA.

Best Practice & Research. Clinical Haematology

|November 24, 2018

Summary

Advances in understanding T-cell acute lymphoblastic leukemia (T-ALL) reveal key drivers, opening new therapeutic avenues. Research explores drugs targeting NOTCH1 and CDKN2A alterations, alongside other targets and immunotherapies for T-ALL treatment.

Keywords:

CDKN2A Chimeric antigen receptor GSI Gamma secretase inhibitor JAK/STAT Mutations NOTCH1 NT5C2CAR NUP214-ABL1 PTEN T-ALL T-cell acute lymphoblastic leukemia

More Related Videos

Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization

Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization

Published on: May 15, 2018

Molecular Imaging to Target Transplanted Muscle Progenitor Cells

Molecular Imaging to Target Transplanted Muscle Progenitor Cells

Published on: March 27, 2013

Related Experiment Videos

Last Updated: Feb 2, 2026

Author Spotlight: Advancing Metabolomics Analysis of Rare Hematopoietic Stem Cells

Author Spotlight: Advancing Metabolomics Analysis of Rare Hematopoietic Stem Cells

Published on: February 23, 2024

Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization

Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization

Published on: May 15, 2018

Molecular Imaging to Target Transplanted Muscle Progenitor Cells

Molecular Imaging to Target Transplanted Muscle Progenitor Cells

Published on: March 27, 2013

Area of Science:

Hematology
Oncology
Molecular Biology

Background:

T-cell acute lymphoblastic leukemia (T-ALL) is a significant hematologic malignancy.
Understanding the molecular underpinnings of T-ALL is crucial for developing effective treatments.

Purpose of the Study:

To review the molecular basis of T-ALL.
To discuss key genes, pathways, and mechanisms driving T-ALL pathobiology.
To identify and discuss potential therapeutic targets for T-ALL.

Main Methods:

Literature review of T-ALL pathobiology.
Analysis of genetic alterations and their role in T-ALL.
Discussion of current and emerging therapeutic strategies.

Main Results:

Identification of central genes and pathways driving T-ALL.
NOTCH1 and CDKN2A genetic alterations are prevalent and targeted by new therapies.
Multiple other therapeutic targets and immunotherapies are under investigation.

Conclusions:

Progress in understanding T-ALL molecular drivers offers new therapeutic opportunities.
Targeting specific genetic alterations like NOTCH1 and CDKN2A shows promise.
Further investigation into diverse therapeutic targets and immunotherapies is warranted for T-ALL treatment.